Eagle Bay Advisors LLC Bristol Myers Squibb CO Transaction History
Eagle Bay Advisors LLC
- $163 Million
- Q2 2024
A detailed history of Eagle Bay Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 7,559 shares of BMY stock, worth $409,546. This represents 0.19% of its overall portfolio holdings.
Number of Shares
7,559
Previous 8,170
7.48%
Holding current value
$409,546
Previous $443,000
29.35%
% of portfolio
0.19%
Previous 0.28%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,404Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10.1 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.6 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.95 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.04 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.2 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...